CINJ Grand Rounds –
“NOS2 and COX2 as Major Drivers of Poor Outcomes in ER – Breast Cancer.
New Therapeutic Opportunities in a Difficult Disease”
Speaker: David Wink, PhD, AAS Fellow; Deputy Director for Translational Sciences, Cancer Inflamation Program, National Cancer Institute
Pre-registration is required.
Register here